Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 8Active not recruiting 6Terminated 2Not yet recruiting 2Enrolling by invitation 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 2Standard of Care 2Methods 2Interviews as Topic 2Educational Status 2Early Intervention, Educational 2Counseling 2Blood Specimen Collection 2zilucoplan 1sacituzumab govitecan 1rozanolixizumab 1oxycodone-acetaminophen 1ibrutinib 1erdafitinib 1enzalutamide 1enfortumab vedotin 1dynorphin-converting endopeptidase 1durvalumab 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1avelumab 1Vinblastine 1Tramadol 1Surgical Procedures, Operative 1Stents 1Specimen Handling 1Semen Analysis 1Robotic Surgical Procedures 1Protons 1Pregabalin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Methods × 30 days × Clear all
NCT06744595 2026-05-26

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Mayo Clinic

Phase NA Enrolling by invitation
40 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06822530 2026-05-11

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Fred Hutchinson Cancer Center

Phase NA Enrolling by invitation
682 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡